Limited efficacy of HLA-haploidentical peripheral blood stem cell infusion in treatment of elderly patients with acute myelogenous leukaemia

Investor logo

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ŠUSTKOVÁ Zuzana JEŽÍŠKOVÁ Ivana DVOŘÁKOVÁ Dana HORKÝ Ondřej SEMERÁD Lukáš WEINBERGEROVÁ Barbora ČULEN Martin MAYER Jiří RÁČIL Zdeněk

Year of publication 2017
Type Article in Periodical
Magazine / Source Hematological Oncology
MU Faculty or unit

Faculty of Medicine

Citation
Web http://onlinelibrary.wiley.com/doi/10.1002/hon.2254/abstract
Doi http://dx.doi.org/10.1002/hon.2254
Field Oncology and hematology
Keywords acute myelogenous leukaemia; immunotherapy; elderly patients
Attached files
Description The study showed no benefit of adding HLA-haploidentical PBSC infusion to intensive chemotherapy over standard treatment in elderly AML patients.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info